Table of Contents Author Guidelines Submit a Manuscript
Journal of Lipids
Volume 2018 (2018), Article ID 3646725, 11 pages
https://doi.org/10.1155/2018/3646725
Review Article

Ceramide and Ischemia/Reperfusion Injury

Department of Genetics & Genomic Sciences, Icahn School of Medicine at Mount Sinai, 1425 Madison Avenue, New York, NY 10029, USA

Correspondence should be addressed to Edward H. Schuchman; ude.mssm@namhcuhcs.drawde

Received 2 October 2017; Accepted 21 December 2017; Published 21 January 2018

Academic Editor: Afaf El-Ansary

Copyright © 2018 Xingxuan He and Edward H. Schuchman. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. T. Okazaki, A. Bielawska, R. M. Bell et al., “Role of ceramide as a lipid mediator of 1 alpha, 25-dihydroxyvitamin D3-induced HL-60 cell differentiation,” The Journal of Biological Chemistry, vol. 265, no. 26, pp. 15823–15831, 1990. View at Google Scholar
  2. E. Gulbins and R. Kolesnick, “Acid sphingomyelinase-derived ceramide signaling in apoptosis,” Subcellular Biochemistry, vol. 36, pp. 229–244, 2002. View at Google Scholar
  3. Y. H. Zeidan and Y. A. Hannun, “The acid sphingomyelinase/ceramide pathway: Biomedical significance and mechanisms of regulation,” Current Molecular Medicine, vol. 10, no. 5, pp. 454–466, 2010. View at Publisher · View at Google Scholar · View at Scopus
  4. X. He and E. H. Schuchman, “Potential role of acid sphingomyelinase in environmental health,” Zhong Nan Da Xue Xue Bao Yi Xue Ban, vol. 37, no. 2, pp. 109–125, 2012. View at Google Scholar
  5. E. Gulbins and R. Kolesnick, “Raft ceramide in molecular medicine,” Oncogene, vol. 22, no. 45, pp. 7070–7077, 2003. View at Publisher · View at Google Scholar · View at Scopus
  6. E. L. Smith and E. H. Schuchman, “The unexpected role of acid sphingomyelinase in cell death and the pathophysiology of common diseases,” The FASEB Journal, vol. 22, no. 10, pp. 3419–3431, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. E. Gulbins, “Regulation of death receptor signaling and apoptosis by ceramide,” Pharmacological Research, vol. 47, no. 5, pp. 393–399, 2003. View at Publisher · View at Google Scholar · View at Scopus
  8. J. A. Chavez and S. A. Summers, “A ceramide-centric view of insulin resistance,” Cell Metabolism, vol. 15, no. 5, pp. 585–594, 2012. View at Publisher · View at Google Scholar · View at Scopus
  9. W. Doehner, A. C. Bunck, M. Rauchhaus et al., “Secretory sphingomyelinase is upregulated in chronic heart failure: A second messenger system of immune activation relates to body composition, muscular functional capacity, and peripheral blood flow,” European Heart Journal, vol. 28, no. 7, pp. 821–828, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. W. Pan, J. Yu, R. Shi et al., “Elevation of ceramide and activation of secretory acid sphingomyelinase in patients with acute coronary syndromes,” Coronary Artery Disease, vol. 25, no. 3, pp. 230–235, 2014. View at Publisher · View at Google Scholar · View at Scopus
  11. X. He, Y. Huang, B. Li, C.-X. Gong, and E. H. Schuchman, “Deregulation of sphingolipid metabolism in Alzheimer's disease,” Neurobiology of Aging, vol. 31, no. 3, pp. 398–408, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. S. Patil, J. Melrose, and C. Chan, “Involvement of astroglial ceramide in palmitic acid-induced Alzheimer-like changes in primary neurons,” European Journal of Neuroscience, vol. 26, no. 8, pp. 2131–2141, 2007. View at Publisher · View at Google Scholar · View at Scopus
  13. P. Biberthaler, B. Luchting, S. Massberg et al., “Ischemia at 4°C: A novel mouse model to investigate the effect of hypothermia on postiscnemic hepatic microcirculatory injury,” Research in Experimental Medicine, vol. 200, no. 2, pp. 93–105, 2001. View at Publisher · View at Google Scholar · View at Scopus
  14. C. A. Bradham, R. F. Stachlewitz, W. Gao et al., “Reperfusion after liver transplantation in rats differentially activates the mitogen-activated protein kinases,” Hepatology, vol. 25, no. 5, pp. 1128–1135, 1997. View at Publisher · View at Google Scholar · View at Scopus
  15. A. E. Bielawska, J. P. Shapiro, and L. Jiang, “Ceramide is involved in triggering of cardiomyocyte apoptosis induced by ischemia and reperfusion,” American Journal of Pathology, vol. 151, no. 5, pp. 1257–1263, 1997. View at Google Scholar
  16. R. A. Zager, M. Iwata, D. S. Conrad, K. M. Burkhart, and Y. Igarashi, “Altered ceramide and sphingosine expression during the induction phase of ischemic acute renal failure,” Kidney International, vol. 52, no. 1, pp. 60–70, 1997. View at Publisher · View at Google Scholar · View at Scopus
  17. W.-C. Liao, A. Haimovitz-Friedman, R. S. Persaud et al., “Ataxia telangiectasia-mutated gene product inhibits DNA damage-induced apoptosis via ceramide synthase,” The Journal of Biological Chemistry, vol. 274, no. 25, pp. 17908–17917, 1999. View at Publisher · View at Google Scholar · View at Scopus
  18. M. Kubota, K. Narita, T. Nakagomi et al., “Sphingomyelin changes in rat cerebral cortex during focal ischemia,” Neurological Research, vol. 18, no. 4, pp. 337–341, 1996. View at Publisher · View at Google Scholar · View at Scopus
  19. M. Nakane, M. Kubota, T. Nakagomi et al., “Lethal forebrain ischemia stimulates sphingomyelin hydrolysis and ceramide generation in the gerbil hippocampus,” Neuroscience Letters, vol. 296, no. 2-3, pp. 89–92, 2000. View at Publisher · View at Google Scholar · View at Scopus
  20. I. Ramirez-Camacho, R. Bautista-Perez, F. Correa et al., “Role of sphingomyelinase in mitochondrial ceramide accumulation during reperfusion,” Biochimica et Biophysica Acta, vol. 1862, no. 10, pp. 1955–1963, 2016. View at Publisher · View at Google Scholar · View at Scopus
  21. H. Tuzcu, B. Unal, E. Kırac et al., “Neutral sphingomyelinase inhibition alleviates apoptosis, but not ER stress, in liver ischemia–reperfusion injury,” Free Radical Research, vol. 51, no. 3, pp. 253–268, 2017. View at Publisher · View at Google Scholar · View at Scopus
  22. B. Unal, F. Ozcan, H. Tuzcu, E. Kırac, G. O. Elpek, and M. Aslan, “Inhibition of neutral sphingomyelinase decreases elevated levels of nitrative and oxidative stress markers in liver ischemia–reperfusion injury,” Redox Report, vol. 22, no. 4, pp. 147–159, 2017. View at Publisher · View at Google Scholar · View at Scopus
  23. R. A. Zager, S. Conrad, K. Lochhead, E. A. Sweeney, Y. Igarashi, and K. M. Burkhart, “Altered sphingomyelinase and ceramide expression in the setting of ischemic and nephrotoxic acute renal failure,” Kidney International, vol. 53, no. 3, pp. 573–582, 1998. View at Publisher · View at Google Scholar · View at Scopus
  24. O. M. Hernandez, D. J. Discher, N. H. Bishopric, and K. A. Webster, “Rapid activation of neutral sphingomyelinase by hypoxia-reoxygenation of cardiac myocytes,” Circulation Research, vol. 86, no. 2, pp. 198–204, 2000. View at Publisher · View at Google Scholar · View at Scopus
  25. N. W. O'Brien, N. M. Gellings, M. Guo, S. B. Barlow, C. C. Glembotski, and R. A. Sabbadini, “Factor associated with neutral sphingomyelinase activation and its role in cardiac cell death,” Circulation Research, vol. 92, no. 6, pp. 589–591, 2003. View at Publisher · View at Google Scholar · View at Scopus
  26. P. H. Chan, “Reactive Oxygen Radicals in Signaling and Damage in the Ischemic Brain,” Journal of Cerebral Blood Flow & Metabolism, vol. 21, no. 1, pp. 2–14, 2001. View at Google Scholar
  27. N. Suematsu, H. Tsutsui, J. Wen et al., “Oxidative stress mediates tumor necrosis factor-α-induced mitochondrial DNA damage and dysfunction in cardiac myocytes,” Circulation, vol. 107, no. 10, pp. 1418–1423, 2003. View at Publisher · View at Google Scholar · View at Scopus
  28. J.-S. Won and I. Singh, “Sphingolipid signaling and redox regulation,” Free Radical Biology & Medicine, vol. 40, no. 11, pp. 1875–1888, 2006. View at Publisher · View at Google Scholar · View at Scopus
  29. J. Fan, B. X. Wu, and C. E. Crosson, “Suppression of acid sphingomyelinase protects the retina from ischemic injury,” Investigative Ophthalmology & Visual Science, vol. 57, no. 10, pp. 4476–4484, 2016. View at Publisher · View at Google Scholar · View at Scopus
  30. A. V. Alessenko, E. I. Galperin, L. B. Dudnik et al., “Role of tumor necrosis factor alpha and sphingomyelin cycle activation in the induction of apoptosis by ischemia/reperfusion of the liver,” Biochemistry, vol. 67, no. 12, pp. 1347–1355, 2002. View at Google Scholar
  31. A. Strelow, K. Bernardo, S. Adam-Klages et al., “Overexpression of acid ceramidase protects from tumor necrosis factor-induced cell death,” The Journal of Experimental Medicine, vol. 192, no. 5, pp. 601–611, 2000. View at Publisher · View at Google Scholar · View at Scopus
  32. N. Teoh, J. Field, J. Sutton, and G. Farrell, “Dual Role of Tumor Necrosis Factor-α in Hepatic Ischemia-Reperfusion Injury: Studies in Tumor Necrosis Factor-α Gene Knockout Mice,” Hepatology, vol. 39, no. 2, pp. 412–421, 2004. View at Publisher · View at Google Scholar · View at Scopus
  33. S. Lecour, P. Owira, and L. H. Opie, “Ceramide-induced preconditioning involves reactive oxygen species,” Life Sciences, vol. 78, no. 15, pp. 1702–1706, 2006. View at Publisher · View at Google Scholar · View at Scopus
  34. D. Pchejetski, O. Kunduzova, A. Dayon et al., “Oxidative stress-dependent sphingosine kinase-1 inhibition mediates monoamine oxidase A-associated cardiac cell apoptosis,” Circulation Research, vol. 100, no. 1, pp. 41–49, 2007. View at Publisher · View at Google Scholar · View at Scopus
  35. L. Llacuna, M. Mari, C. Garcia-Ruiz, J. C. Fernandez-Checa, and A. Morales, “Critical role of acidic sphingomyelinase in murine hepatic ischemia-reperfusion injury,” Hepatology, vol. 44, no. 3, pp. 561–572, 2006. View at Publisher · View at Google Scholar · View at Scopus
  36. Z. F. Yu, M. Nikolova-Karakashian, D. Zhou, G. Cheng, E. H. Schuchman, and M. P. Mattson, “Pivotal role for acidic sphingomyelinase in cerebral ischemia-induced ceramide and cytokine production, and neuronal apoptosis,” Journal of Molecular Neuroscience, vol. 15, no. 2, pp. 85–97, 2000. View at Publisher · View at Google Scholar · View at Scopus
  37. M. R. Reforgiato, G. Milano, G. Fabriàs et al., “Inhibition of ceramide de novo synthesis as a postischemic strategy to reduce myocardial reperfusion injury,” Basic Research in Cardiology, vol. 111, no. 2, article no. 12, 2016. View at Publisher · View at Google Scholar · View at Scopus
  38. E. C. Mandon, I. Ehses, J. Rother, G. Van Echten, and K. Sandhoff, “Subcellular localization and membrane topology of serine palmitoyltransferase, 3-dehydrosphinganine reductase, and sphinganine N- acyltransferase in mouse liver,” The Journal of Biological Chemistry, vol. 267, no. 16, pp. 11144–11148, 1992. View at Google Scholar · View at Scopus
  39. A. H. Futerman, B. Stieger, A. L. Hubbard, and R. E. Pagano, “Sphingomyelin synthesis in rat liver occurs predominantly at the cis and medial cisternae of the Golgi apparatus,” The Journal of Biological Chemistry, vol. 265, no. 15, pp. 8650–8657, 1990. View at Google Scholar · View at Scopus
  40. A. H. Futerman and H. Riezman, “The ins and outs of sphingolipid synthesis,” Trends in Cell Biology, vol. 15, no. 6, pp. 312–318, 2005. View at Publisher · View at Google Scholar · View at Scopus
  41. Y. Mizutani, A. Kihara, and Y. Igarashi, “Mammalian Lass6 and its related family members regulate synthesis of specific ceramides,” Biochemical Journal, vol. 390, no. 1, pp. 263–271, 2005. View at Publisher · View at Google Scholar · View at Scopus
  42. F. D. Testai, J. P. Kilkus, E. Berdyshev, I. Gorshkova, V. Natarajan, and G. Dawson, “Multiple sphingolipid abnormalities following cerebral microendothelial hypoxia,” Journal of Neurochemistry, vol. 131, no. 4, pp. 530–540, 2014. View at Publisher · View at Google Scholar · View at Scopus
  43. J. Yu, S. A. Novgorodov, D. Chudakova et al., “JNK3 signaling pathway activates ceramide synthase leading to mitochondrial dysfunction,” The Journal of Biological Chemistry, vol. 282, no. 35, pp. 25940–25949, 2007. View at Publisher · View at Google Scholar · View at Scopus
  44. H.-P. Tian, T.-Z. Qiu, J. Zhao, L.-X. Li, and J. Guo, “Sphingomyelinase-induced ceramide production stimulate calcium-independent JNK and PP2A activation following cerebral ischemia,” Brain Injury, vol. 23, no. 13-14, pp. 1073–1080, 2009. View at Publisher · View at Google Scholar · View at Scopus
  45. J. Jin, Q. Hou, T. D. Mullen et al., “Ceramide generated by sphingomyelin hydrolysis and the salvage pathway is involved in hypoxia/reoxygenation-induced bax redistribution to mitochondria in NT-2 cells,” The Journal of Biological Chemistry, vol. 283, no. 39, pp. 26509–26517, 2008. View at Publisher · View at Google Scholar · View at Scopus
  46. D. X. Zhang, R. M. Fryer, A. K. Hsu et al., “Production and metabolism of ceramide in normal and ischemic-reperfused myocardium of rats,” Basic Research in Cardiology, vol. 96, no. 3, pp. 267–274, 2001. View at Publisher · View at Google Scholar · View at Scopus
  47. K. Takahashi, I. Ginis, R. Nishioka et al., “Glucosylceramide synthase activity and ceramide levels are modulated during cerebral ischemia after ischemic preconditioning,” Journal of Cerebral Blood Flow & Metabolism, vol. 24, no. 6, pp. 623–627, 2004. View at Google Scholar
  48. D. Ardail, I. Popa, K. Alcantara et al., “Occurrence of ceramides and neutral glycolipids with unusual long-chain base composition in purified rat liver mitochondria,” FEBS Letters, vol. 488, no. 3, pp. 160–164, 2001. View at Publisher · View at Google Scholar · View at Scopus
  49. T. Yabu, A. Shimuzu, and M. Yamashita, “A novel mitochondrial sphingomyelinase in zebrafish cells,” The Journal of Biological Chemistry, vol. 284, no. 30, pp. 20349–20363, 2009. View at Publisher · View at Google Scholar · View at Scopus
  50. B. X. Wu, V. Rajagopalan, P. L. Roddy, C. J. Clarke, and Y. A. Hannun, “Identification and characterization of murine mitochondria-associated neutral sphingomyelinase (MA-nSMase), the mammalian sphingomyelin phosphodiesterase 5,” The Journal of Biological Chemistry, vol. 285, no. 23, pp. 17993–18002, 2010. View at Publisher · View at Google Scholar · View at Scopus
  51. H. Shimeno, S. Soeda, M. Yasukouchi, N. Okamura, and A. Nagamatsu, “Fatty Acyl-Co A: Sphingosine acyltransferase in bovine brain mitochondria: Its solubilization and reconstitution onto the membrane lipid liposomes,” Biological & Pharmaceutical Bulletin, vol. 18, no. 10, pp. 1335–1339, 1995. View at Publisher · View at Google Scholar · View at Scopus
  52. C. Bionda, J. Portoukalian, D. Schmitt, C. Rodriguez-Lafrasse, and D. Ardail, “Subcellular compartmentalization of ceramide metabolism: MAM (mitochondria-associated membrane) and/or mitochondria?” Biochemical Journal, vol. 382, no. 2, pp. 527–533, 2004. View at Publisher · View at Google Scholar · View at Scopus
  53. S. A. Novgorodov, D. A. Chudakova, B. W. Wheeler et al., “Developmentally regulated ceramide synthase 6 increases mitochondrial Ca2+ loading capacity and promotes apoptosis,” The Journal of Biological Chemistry, vol. 286, no. 6, pp. 4644–4658, 2011. View at Publisher · View at Google Scholar · View at Scopus
  54. S. A. Novgorodov, B. X. Wu, T. I. Gudz et al., “Novel pathway of ceramide production in mitochondria: Thioesterase and neutral ceramidase produce ceramide from sphingosine and acyl-CoA,” The Journal of Biological Chemistry, vol. 286, no. 28, pp. 25352–25362, 2011. View at Publisher · View at Google Scholar · View at Scopus
  55. J. Stiban, L. Caputo, and M. Colombini, “Ceramide synthesis in the endoplasmic reticulum can permeabilize mitochondria to proapoptotic proteins,” Journal of Lipid Research, vol. 49, no. 3, pp. 625–634, 2008. View at Publisher · View at Google Scholar · View at Scopus
  56. M. P. Murphy, “How mitochondria produce reactive oxygen species,” Biochemical Journal, vol. 417, no. 1, pp. 1–13, 2009. View at Publisher · View at Google Scholar · View at Scopus
  57. X. Zhang, B. Li, Y. Zhang et al., “Mitochondrial changes in apoptosis of HT-29 cells induced by C2-ceramide,” Wei Sheng Yan Jiu, vol. 37, no. 5, pp. 558-559, 2008. View at Google Scholar
  58. M. Xin and X. Deng, “Protein phosphatase 2A enhances the proapoptotic function of Bax through dephosphorylation,” The Journal of Biological Chemistry, vol. 281, no. 27, pp. 18859–18867, 2006. View at Publisher · View at Google Scholar · View at Scopus
  59. A. Garcia, X. Cayla, J. Guergnon et al., “Serine/threonine protein phosphatases PP1 and PP2A are key players in apoptosis,” Biochimie, vol. 85, no. 8, pp. 721–726, 2003. View at Publisher · View at Google Scholar · View at Scopus
  60. C. L. Murriel, E. Churchill, K. Inagaki, L. I. Szweda, and D. Mochly-Rosen, “Protein kinase Cδ activation induces apoptosis in response to cardiac ischemia and reperfusion damage: a mechanism involving bad and the mitochondria,” The Journal of Biological Chemistry, vol. 279, no. 46, pp. 47985–47991, 2004. View at Publisher · View at Google Scholar · View at Scopus
  61. C. R. Weston and R. J. Davis, “The JNK signal transduction pathway,” Current Opinion in Cell Biology, vol. 19, no. 2, pp. 142–149, 2007. View at Publisher · View at Google Scholar · View at Scopus
  62. M. Di Paola, P. Zaccagnino, G. Montedoro, T. Cocco, and M. Lorusso, “Ceramide induces release of pro-apoptotic proteins from mitochondria by either a Ca2+-dependent or a Ca2+-independent mechanism,” Journal of Bioenergetics and Biomembranes, vol. 36, no. 2, pp. 165–170, 2004. View at Publisher · View at Google Scholar · View at Scopus
  63. S. A. Novgorodov, C. L. Riley, J. A. Keffler et al., “SIRT3 deacetylates ceramide synthases: Implications for mitochondrial dysfunction and brain injury,” The Journal of Biological Chemistry, vol. 291, no. 4, pp. 1957–1973, 2016. View at Publisher · View at Google Scholar · View at Scopus
  64. L. J. Siskind, R. N. Kolesnick, and M. Colombini, “Ceramide forms channels in mitochondrial outer membranes at physiologically relevant concentrations,” Mitochondrion, vol. 6, no. 3, pp. 118–125, 2006. View at Publisher · View at Google Scholar · View at Scopus
  65. A. Beresewicz, A. Dobrzyn, and J. Gorski, “Accumulation of specific ceramides in ischemic/reperfused rat heart; effect of ischemic preconditioning,” Journal of Physiology and Pharmacology, vol. 53, no. 3, pp. 371–382, 2002. View at Google Scholar · View at Scopus
  66. L. Argaud, A. Prigent, L. Chalabreysse, J. Loufouat, M. Lagarde, and M. Ovize, “Ceramide in the antiapoptotic effect of ischemic preconditioning,” American Journal of Physiology-Heart and Circulatory Physiology, vol. 286, no. 1, pp. H246–H251, 2004. View at Publisher · View at Google Scholar
  67. F. C. Barone, R. F. White, P. A. Spera et al., “Ischemic preconditioning and brain tolerance: temporal histological and functional outcomes, protein synthesis requirement, and interleukin-1 receptor antagonist and early gene expression,” Stroke, vol. 29, no. 9, pp. 1937–1951, 1998. View at Publisher · View at Google Scholar · View at Scopus
  68. Z. Cao, Y. Yuan, G. Jeyabalan et al., “Preactivation of NKT cells with α-GalCer protects against hepatic ischemia-reperfusion injury in mouse by a mechanism involving IL-13 and adenosine A2A receptor,” American Journal of Physiology-Gastrointestinal and Liver Physiology, vol. 297, no. 2, pp. G249–G258, 2009. View at Publisher · View at Google Scholar · View at Scopus
  69. J. Mitoma, M. Ito, S. Furuya, and Y. Hirabayashi, “Bipotential roles of ceramide in the growth of hippocampal neurons: Promotion of cell survival and dendritic outgrowth in dose-and developmental stage-dependent manners,” Journal of Neuroscience Research, vol. 51, no. 6, pp. 712–722, 1998. View at Publisher · View at Google Scholar · View at Scopus
  70. S. Willaime, P. Vanhoutte, J. Caboche, Y. Lemaigre-Dubreuil, J. Mariani, and B. Brugg, “Ceramide-induced apoptosis in cortical neurons is mediated by an increase in p38 phosphorylation and not by the decrease in ERK phosphorylation,” European Journal of Neuroscience, vol. 13, no. 11, pp. 2037–2046, 2001. View at Publisher · View at Google Scholar · View at Scopus
  71. M. I. H. Bhuiyan, M. N. Islam, S. Y. Jung, H. H. Yoo, Y. S. Lee, and C. Jin, “Involvement of ceramide in ischemic tolerance induced by preconditioning with sublethal oxygen-glucose deprivation in primary cultured cortical neurons of rats,” Biological & Pharmaceutical Bulletin, vol. 33, no. 1, pp. 11–17, 2010. View at Publisher · View at Google Scholar · View at Scopus
  72. D. M. Yellon and J. M. Downey, “Preconditioning the myocardium: from cellular physiology to clinical cardiology,” Physiological Reviews, vol. 83, no. 4, pp. 1113–1151, 2003. View at Publisher · View at Google Scholar · View at Scopus
  73. S. Lecour, M. N. Sack, and L. H. Opie, “Sphingolipid signaling: a potential pathway for TNF-alpha induced preconditioning,” Annales De Cardiologie Et D'Angeiologie, vol. 52, no. 6, pp. 363–369, 2003. View at Google Scholar
  74. S. Lecour, L. Rochette, and L. Opie, “Free radicals trigger TNFα-induced cardioprotection,” Cardiovascular Research, vol. 65, no. 1, pp. 239–243, 2005. View at Publisher · View at Google Scholar · View at Scopus
  75. C. P. Baines, M. Goto, and J. M. Downey, “Oxygen radicals released during ischemic preconditioning contribute to cardioprotection in the rabbit myocardium,” Journal of Molecular and Cellular Cardiology, vol. 29, no. 1, pp. 207–216, 1997. View at Publisher · View at Google Scholar · View at Scopus
  76. M. Das, J. Cui, and D. K. Das, “Generation of survival signal by differential interaction of p38MAPKα and p38MAPKβ with caveolin-1 and caveolin-3 in the adapted heart,” Journal of Molecular and Cellular Cardiology, vol. 42, no. 1, pp. 206–213, 2007. View at Publisher · View at Google Scholar
  77. P. Der, J. Cui, and D. K. Das, “Role of lipid rafts in ceramide and nitric oxide signaling in the ischemic and preconditioned hearts,” Journal of Molecular and Cellular Cardiology, vol. 40, no. 2, pp. 313–320, 2006. View at Publisher · View at Google Scholar · View at Scopus
  78. S. Spiegel and S. Milstien, “Sphingosine-1-phosphate: an enigmatic signalling lipid,” Nature Reviews Molecular Cell Biology, vol. 4, no. 5, pp. 397–407, 2003. View at Publisher · View at Google Scholar · View at Scopus
  79. S. Lecour, R. M. Smith, B. Woodward, L. H. Opie, L. Rochette, and M. N. Sack, “Identification of a novel role for sphingolipid signaling in TNFα and ischemic preconditioning mediated cardioprotection,” Journal of Molecular and Cellular Cardiology, vol. 34, no. 5, pp. 509–518, 2002. View at Publisher · View at Google Scholar · View at Scopus
  80. Z.-Q. Jin, E. J. Goetzl, and J. S. Karliner, “Sphingosine kinase activation mediates ischemic preconditioning in murine heart,” Circulation, vol. 110, no. 14, pp. 1980–1989, 2004. View at Publisher · View at Google Scholar · View at Scopus
  81. Y. Nishino, I. Webb, and M. S. Marber, “Sphingosine kinase isoforms and cardiac protection,” Cardiovascular Research, vol. 76, no. 1, pp. 3-4, 2007. View at Publisher · View at Google Scholar · View at Scopus
  82. Z.-Q. Jin, J. Zhang, Y. Huang, H. E. Hoover, D. A. Vessey, and J. S. Karliner, “A sphingosine kinase 1 mutation sensitizes the myocardium to ischemia/reperfusion injury,” Cardiovascular Research, vol. 76, no. 1, pp. 41–50, 2007. View at Publisher · View at Google Scholar · View at Scopus
  83. T. M. Vu, A. Ishizu, J. C. Foo et al., “Mfsd2b is essential for the sphingosine-1-phosphate export in erythrocytes and platelets,” Nature, vol. 550, no. 7677, pp. 524–528, 2017. View at Publisher · View at Google Scholar
  84. I. Karunakaran and G. van Echten-Deckert, “Sphingosine 1-phosphate – A double edged sword in the brain,” Biochimica et Biophysica Acta (BBA) - Biomembranes, vol. 1859, no. 9, pp. 1573–1582, 2017. View at Publisher · View at Google Scholar · View at Scopus
  85. J. Qin, E. Berdyshev, J. Goya, V. Natarajan, and G. Dawson, “Neurons and oligodendrocytes recycle sphingosine 1-phosphate to ceramide: significance for apoptosis and multiple sclerosis,” The Journal of Biological Chemistry, vol. 285, no. 19, pp. 14134–14143, 2010. View at Publisher · View at Google Scholar · View at Scopus
  86. E. Usta, M. Mustafi, F. Artunc et al., “The challenge to verify ceramide's role of apoptosis induction in human cardiomyocytes - a pilot study,” Journal of Cardiothoracic Surgery, vol. 6, no. 1, article no. 38, 2011. View at Publisher · View at Google Scholar · View at Scopus
  87. M. Kubota, S. Kitahara, H. Shimasaki, and N. Ueta, “Accumulation of ceramide in ischemic human brain of an acute case of cerebral occlusion,” The Japanese Journal of Experimental Medicine, vol. 59, no. 2, pp. 59–64, 1989. View at Google Scholar · View at Scopus
  88. I. Herr, A. Martin-Villalba, E. Kurz et al., “FK506 prevents stroke-induced generation of ceramide and apoptosis signaling,” Brain Research, vol. 826, no. 2, pp. 210–219, 1999. View at Publisher · View at Google Scholar · View at Scopus
  89. J. Liu, I. Ginis, M. Spatz, and J. M. Hallenbeck, “Hypoxic preconditioning protects cultured neurons against hypoxic stress via TNF-α and ceramide,” American Journal of Physiology-Cell Physiology, vol. 278, no. 1, pp. C144–C153, 2000. View at Publisher · View at Google Scholar
  90. D. A. Chudakova, Y. H. Zeidan, B. W. Wheeler et al., “Integrin-associated Lyn kinase promotes cell survival by suppressing acid sphingomyelinase activity,” The Journal of Biological Chemistry, vol. 283, no. 43, pp. 28806–28816, 2008. View at Publisher · View at Google Scholar · View at Scopus
  91. J. K. Yun and M. Kester, “Regulatory role of sphingomyelin metabolites in hypoxia-induced vascular smooth muscle cell proliferation,” Archives of Biochemistry and Biophysics, vol. 408, no. 1, pp. 78–86, 2002. View at Publisher · View at Google Scholar · View at Scopus
  92. A. Gomez-Munoz, J. Kong, B. Salh, and U. P. Steinbrecher, “Sphingosine-1-phosphate inhibits acid sphingomyelinase and blocks apoptosis in macrophages,” FEBS Letters, vol. 539, no. 1-3, pp. 56–60, 2003. View at Publisher · View at Google Scholar · View at Scopus
  93. T. Kalhorn and R. A. Zager, “Renal cortical ceramide patterns during ischemic and toxic injury: Assessments by HPLC-mass spectrometry,” American Journal of Physiology-Renal Physiology, vol. 277, no. 5, pp. F723–F733, 1999. View at Publisher · View at Google Scholar · View at Scopus
  94. Y. Itoh, T. Yano, T. Sendo et al., “Involvement of de novo ceramide synthesis in radiocontrast-induced renal tubular cell injury,” Kidney International, vol. 69, no. 2, pp. 288–297, 2006. View at Publisher · View at Google Scholar · View at Scopus
  95. S. Homer-Vanniasinkam, J. N. Crinnion, and M. J. Gough, “Post-ischaemic organ dysfunction: A review,” European Journal of Vascular and Endovascular Surgery, vol. 14, no. 3, pp. 195–203, 1997. View at Publisher · View at Google Scholar · View at Scopus
  96. H. Mitsuoka, E. B. Kistler, and G. W. Schmid-Schönbein, “Protease inhibition in the intestinal lumen: Attenuation of systemic inflammation and early indicators of multiple organ failure in shock,” Shock, vol. 17, no. 3, pp. 205–209, 2002. View at Publisher · View at Google Scholar · View at Scopus
  97. Z. Sun, X. Wang, X. Deng et al., “The influence of intestinal ischemia and reperfusion on bidirectional intestinal barrier permeability, cellular membrane integrity, proteinase inhibitors, and cell death in rats,” Shock, vol. 10, no. 3, pp. 203–212, 1998. View at Publisher · View at Google Scholar · View at Scopus
  98. T. Noda, R. Iwakiri, K. Fujimoto, S. Matsuo, and T. Y. Aw, “Programmed cell death induced by ischemia-reperfusion in rat intestinal mucosa,” American Journal of Physiology-Gastrointestinal and Liver Physiology, vol. 274, no. 2, pp. G270–G276, 1998. View at Publisher · View at Google Scholar
  99. K.-X. Liu, W. He, T. Rinne, Y. Liu, M.-Q. Zhao, and W.-K. Wu, “The effect of Ginkgo biloba extract (EGb 761) pretreatment on intestinal epithelial apoptosis induced by intestinal ischemia/reperfusion in rats: role of ceramide,” American Journal of Chinese Medicine, vol. 35, no. 5, pp. 805–819, 2007. View at Publisher · View at Google Scholar · View at Scopus
  100. K.-X. Liu, S.-Q. Chen, W.-Q. Huang, Y.-S. Li, M. G. Irwin, and Z. Xia, “Propofol pretreatment reduces ceramide production and attenuates intestinal mucosal apoptosis induced by intestinal ischemia/reperfusion in rats,” Anesthesia & Analgesia, vol. 107, no. 6, pp. 1884–1891, 2008. View at Publisher · View at Google Scholar · View at Scopus
  101. L. Wei, A. Wedeking, R. Büttner, J. C. Kalff, R. H. Tolba, and G. Van Echten-Deckert, “A natural tetrahydropyrimidine protects small bowel from cold ischemia and subsequent warm in vitro reperfusion injury,” Pathobiology, vol. 76, no. 4, pp. 212–220, 2009. View at Publisher · View at Google Scholar · View at Scopus
  102. S. Cuzzocrea, R. Di Paola, T. Genovese et al., “Anti-inflammatory and anti-apoptotic effects of fumonisin B1, an inhibitor of ceramide synthase, in a rodent model of splanchnic ischemia and reperfusion injury,” The Journal of Pharmacology and Experimental Therapeutics, vol. 327, no. 1, pp. 45–57, 2008. View at Publisher · View at Google Scholar · View at Scopus